Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Galli

Showing results (481-490 of 534) with videos related to

Pageof 54
Sort By:
Toxicology Letters|May 15, 2019
Development of a consensus approach for botanical safety evaluation - A roundtable reportCorrado L Galli, Nigel J Walker, Nicholas H Oberlies, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 15, 2013
Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort studyD J F Stuijver, E Piantanida, B van Zaane, et al.
Scientific Reports|May 18, 2021
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19V Spagnuolo, M Guffanti, L Galli, et al.
Physics in Medicine and Biology|August 7, 2020
BrachyView: development of an algorithm for real-time automatic LDR brachytherapy seed detectionT Brennen, L Galli, D L Cutajar, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 19, 2015
Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trialM Ripa, M Pogliaghi, S Chiappetta, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN studyS Nozza, L Galli, A Antinori, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 29, 2019
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patientsR Ungaro, L Taramasso, B Bruzzone, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 30, 2013
Prevalence of etravirine (ETR)-RAMs at NNRTI failure and predictors of resistance to ETR in a large Italian resistance database (ARCA)S Rusconi, F Adorni, B Bruzzone, et al.
Toxicology Letters|December 19, 2016
Insights on wood combustion generated proinflammatory ultrafine particles (UFP)Emanuela Corsini, Senem Ozgen, Angela Papale, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 15, 2020
Management of cytomegalovirus infection in pregnancy: is it time for valacyclovir?L Zammarchi, T Lazzarotto, M Andreoni, et al.
Pageof 54

Showing results (481-490 of 534) with videos related to

Sort By:
Pageof 54
Toxicology Letters|May 15, 2019
Development of a consensus approach for botanical safety evaluation - A roundtable reportCorrado L Galli, Nigel J Walker, Nicholas H Oberlies, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 15, 2013
Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort studyD J F Stuijver, E Piantanida, B van Zaane, et al.
Scientific Reports|May 18, 2021
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19V Spagnuolo, M Guffanti, L Galli, et al.
Physics in Medicine and Biology|August 7, 2020
BrachyView: development of an algorithm for real-time automatic LDR brachytherapy seed detectionT Brennen, L Galli, D L Cutajar, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 19, 2015
Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trialM Ripa, M Pogliaghi, S Chiappetta, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN studyS Nozza, L Galli, A Antinori, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 29, 2019
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patientsR Ungaro, L Taramasso, B Bruzzone, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 30, 2013
Prevalence of etravirine (ETR)-RAMs at NNRTI failure and predictors of resistance to ETR in a large Italian resistance database (ARCA)S Rusconi, F Adorni, B Bruzzone, et al.
Toxicology Letters|December 19, 2016
Insights on wood combustion generated proinflammatory ultrafine particles (UFP)Emanuela Corsini, Senem Ozgen, Angela Papale, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 15, 2020
Management of cytomegalovirus infection in pregnancy: is it time for valacyclovir?L Zammarchi, T Lazzarotto, M Andreoni, et al.
Pageof 54